Your Article Summary
See Latest ArticlesSmart planner: radically accelerating R and D to combat a biothreat
Drug Development Research, 06/19/09
Chadwick AT et al. - The tool incorporates the following capabilities: visualization of the risks of inaction; identification of critical areas of uncertainty where new information can really make a difference; decision support for development and treatment options and optimization of tradeoffs given various timescales. The tool facilitates alignment of research planners' acceptance of risks with policy-makers' strategic views of benefits in the context of apparent or overt threats.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
GlaxoSmithKline and NanoBio announce OTC licensing agreement for cold sore treatment
GlaxoSmithKline, 12/18/09
ARIAD Announces Full Enrollment in Phase 3 Succeed Trial Evaluating Ridaforolimus in Patients with Metastatic Sarcomas
ARIAD Pharmaceuticals, 12/18/09
CCHIT Appoints Officers
HealthDataManagement, 12/18/09